Literature DB >> 25918439

Surveillance of antibiotic resistance.

Alan P Johnson1.   

Abstract

Surveillance involves the collection and analysis of data for the detection and monitoring of threats to public health. Surveillance should also inform as to the epidemiology of the threat and its burden in the population. A further key component of surveillance is the timely feedback of data to stakeholders with a view to generating action aimed at reducing or preventing the public health threat being monitored. Surveillance of antibiotic resistance involves the collection of antibiotic susceptibility test results undertaken by microbiology laboratories on bacteria isolated from clinical samples sent for investigation. Correlation of these data with demographic and clinical data for the patient populations from whom the pathogens were isolated gives insight into the underlying epidemiology and facilitates the formulation of rational interventions aimed at reducing the burden of resistance. This article describes a range of surveillance activities that have been undertaken in the UK over a number of years, together with current interventions being implemented. These activities are not only of national importance but form part of the international response to the global threat posed by antibiotic resistance.
© 2015 The Author(s) Published by the Royal Society. All rights reserved.

Entities:  

Keywords:  antibiotic susceptibility testing; interventions; public health threat

Mesh:

Year:  2015        PMID: 25918439      PMCID: PMC4424431          DOI: 10.1098/rstb.2014.0080

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  74 in total

1.  Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

Authors:  A P Johnson; D C Speller; R C George; M Warner; G Domingue; A Efstratiou
Journal:  BMJ       Date:  1996-06-08

2.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

3.  Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.

Authors:  David M Livermore; Russell Hope; Geraldine Brick; Mark Lillie; Rosy Reynolds
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

4.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

5.  UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone.

Authors:  Siu Ha Lau; Mary E Kaufmann; David M Livermore; Neil Woodford; Geraldine A Willshaw; Tom Cheasty; Katie Stamper; Suganya Reddy; John Cheesbrough; Frederick J Bolton; Andrew J Fox; Mathew Upton
Journal:  J Antimicrob Chemother       Date:  2008-09-08       Impact factor: 5.790

6.  Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.

Authors:  David M Livermore; Tom Nichols; Theresa L Lamagni; Nicola Potz; Rosy Reynolds; Georgia Duckworth
Journal:  J Antimicrob Chemother       Date:  2003-10-29       Impact factor: 5.790

7.  Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001.

Authors:  N Khairulddin; L Bishop; T L Lamagni; M Sharland; G Duckworth
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

8.  Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007.

Authors:  Matthew J Ellington; Russell Hope; David M Livermore; Angela M Kearns; Katherine Henderson; Barry D Cookson; Andrew Pearson; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2009-12-24       Impact factor: 5.790

9.  Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit.

Authors:  James R Price; Tanya Golubchik; Kevin Cole; Daniel J Wilson; Derrick W Crook; Guy E Thwaites; Rory Bowden; A Sarah Walker; Timothy E A Peto; John Paul; Martin J Llewelyn
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

10.  Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

Authors:  Dominique L Monnet; Fiona M MacKenzie; José Maria López-Lozano; Arielle Beyaert; Máximo Camacho; Rachel Wilson; David Stuart; Ian M Gould
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  24 in total

Review 1.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Antibiotics in the clinical pipeline at the end of 2015.

Authors:  Mark S Butler; Mark At Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

3.  Antimicrobial resistance: addressing the threat to global health. Preface.

Authors:  Roy M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

Review 4.  The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.

Authors:  Michelle F Richter; Paul J Hergenrother
Journal:  Ann N Y Acad Sci       Date:  2018-02-15       Impact factor: 5.691

5.  Patterns of Antibiotic Resistance in Enterobacteriaceae Isolates from Broiler Chicken in the West Region of Cameroon: A Cross-Sectional Study.

Authors:  Jude Fonbah Leinyuy; Innocent Mbulli Ali; Ousenu Karimo; Christopher B Tume
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-06-09       Impact factor: 2.585

Review 6.  Crossroads of Antibiotic Resistance and Biosynthesis.

Authors:  Timothy A Wencewicz
Journal:  J Mol Biol       Date:  2019-07-06       Impact factor: 5.469

Review 7.  Polishing the tarnished silver bullet: the quest for new antibiotics.

Authors:  Mark A T Blaskovich; Mark S Butler; Matthew A Cooper
Journal:  Essays Biochem       Date:  2017-03-03       Impact factor: 8.000

8.  Profiling of antibiotic resistance of bacterial species recovered from routine clinical isolates in Ethiopia.

Authors:  Robert-Jan Ten Hove; Melaku Tesfaye; Witold Frederik Ten Hove; Mesfin Nigussie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-06-26       Impact factor: 3.944

9.  Rapid screening for antibiotic resistance elements on the RNA transcript, protein and enzymatic activity level.

Authors:  Alexander Rohde; Jens Andre Hammerl; Sascha Al Dahouk
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-09-23       Impact factor: 3.944

Review 10.  Antibiotic Stewardship Initiatives as Part of the UK 5-Year Antimicrobial Resistance Strategy.

Authors:  Alan P Johnson; Diane Ashiru-Oredope; Elizabeth Beech
Journal:  Antibiotics (Basel)       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.